Drug pipeline 2Q20

Overview of attention for news story in Nature Biotechnology

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 304,967 followers.

RT @NatureBiotech: Our 2Q20 drug pipeline Data Page shows @US_FDA accelerated approvals for cancer indications, including two small molecul…

RT @NatureBiotech: Our 2Q20 drug pipeline Data Page shows @US_FDA accelerated approvals for cancer indications, including two small molecul…

Our 2Q20 drug pipeline Data Page shows @US_FDA accelerated approvals for cancer indications, including two small molecules — @Incyte’s #Pemazyre and @Novartis’s @TABRECTA_US — approved with companion diagnostics from @FoundationATCG https://t.co/ubNlimmAQc